)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Anebulo Pharmaceuticals
Anebulo Pharmaceuticals (ANEB) investor relations material
Anebulo Pharmaceuticals Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary12 Feb, 2026
Executive summary
Focused on developing selonabant, a cannabinoid receptor antagonist, for cannabis-induced toxicity, prioritizing pediatric IV formulation over adult oral product due to unmet medical need and regulatory feedback.
Announced and completed a tender offer to repurchase shares as part of a plan to go private, with subsequent delisting and deregistration from Nasdaq and SEC reporting, effective February 27, 2026, to reduce costs and reporting burdens.
No revenue generated to date; operations funded by equity raises, grants, and a loan facility.
Financial highlights
Net loss for the quarter ended December 31, 2025: $2.0 million ($0.05 per share), improved from $2.5 million ($0.09 per share) in the prior year quarter.
Net loss for the six months ended December 31, 2025: $4.2 million, improved from $4.7 million year-over-year.
Cash and cash equivalents as of December 31, 2025: $9.0 million, with access to an additional $3.0 million via a loan agreement.
Operating expenses for the quarter: $2.6 million, flat year-over-year.
Grant income for the quarter: $0.6 million, up from $0.2 million in the prior year.
Outlook and guidance
Cash and loan facility expected to fund operations for at least 12 months from the filing date.
Research and development expenses expected to increase as clinical studies progress; general and administrative expenses expected to decrease after going private.
Prioritizing development of selonabant IV for pediatric cannabis toxicity, aiming for a faster approval timeline than the adult oral product.
Additional funding will be required to reach commercialization; options include equity, debt, or partnerships.
Ongoing observational study in emergency departments is being amended to focus on pediatric patients.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Anebulo Pharmaceuticals earnings date
Q3 202612 May, 2026
Anebulo Pharmaceuticals
Next Anebulo Pharmaceuticals earnings date
Q3 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing treatments for acute cannabinoid intoxication (ACI) and substance abuse. Its primary product candidate, ANEB-001, is a cannabinoid receptor antagonist aimed at rapidly reversing the effects of cannabinoid overdose. The company is headquartered in Lakeway, Texas, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage